Today, we would like to highlight a very important and inspiring topic – education and professional growth in clinical research. While the field continues to expand, the demand for skilled specialists in Ukraine is growing, and we are excited to contribute our experience and knowledge. At Pharmaxi, we deeply value...
Read more ▸In March 2026, Pharmaxi LLC had the pleasure of attending BIOCHINA 2026, the premier biotech event connecting Europe and Asia. The conference offered a unique view into the global biotech landscape. We were inspired by the remarkable innovation on display — from cutting-edge vaccines to advanced antibody therapies — and...
Read more ▸From March 2-3, 2026, our Director represented Pharmaxi LLC at the SCRS European Site Solutions Summit in Amsterdam — one of the key industry platforms where research sites, CROs, and sponsors come together to discuss practical ways to improve clinical trial operations and strengthen site collaboration. For Pharmaxi, participating in...
Read more ▸We are pleased to share that the SEC of the MOH of Ukraine has developed new Guidelines for Clinical Trials of Medicinal Products for the Treatment and Prevention of Diabetes. This important step provides researchers and sponsors with clearer regulatory guidance to ensure high-quality and patient-focused diabetes studies in Ukraine. It...
Read more ▸
Ukraine officially introduced the "Compassionate Use" program several years ago, following the adoption of bill No. 5736. Thus patients with serious illnesses, including those suffering from oncology and orphan diseases, to access medications that are still in clinical trials. This mechanism allows pharmaceutical companies to provide these drugs for free...
Read more ▸